Brainstorm Cell Therapeutics Inc. (BCLI)

Cost of Revenue

$131.00K

TTM · Period ending: · USD

BCLI logo

BCLI Cost of Revenue

Latest reported$131.00K
BCLI Cost of Revenue ($17.30K → $131.00K)
High-resolution chart · PNG

BCLI cost of revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Brainstorm Cell Therapeutics Inc. Cost of Revenue — Annual fiscal periods (USD)
Period endingCost of Revenue (USD)
0
240,000
265,000
285,000
260,000
219,000
366,000
110,000
85,000
77,000
87,000
0
0
0
0
0
0
0
0
0
0
0
71,700
17,300
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.